Long-term targets

HomeInvestorsCanatu as an investmentLong-term targets

2026 outlook

Canatu continues to see strong long-term potential in its three business focus areas: Semiconductor, Automotive, and Medical Diagnostics.

In accordance with its disclosure policy, Canatu does not issue any specific numerical guidance for the financial year 2026.

  • In the near term, Canatu sees that there are certain factors which affect the revenue visibility and continue to increase the volatility, in the Semiconductor and Automotive businesses.
  • Canatu has ongoing customer negotiations, the timing and outcome of which remain uncertain.
  • The commercial roll-out of ready CNT pellicles, for example, ultimately depends on Canatu’s customers’ processes and timelines.
  • The timeline for obtaining the second CNT100 SEMI reactor customer approval (SAT) is not fully within Canatu’s control, and the risk of delays cannot therefore be excluded.

Long-term targets

Due to the ongoing strategy update, slower‑than‑expected market transition and recent delays especially in anticipated new customer projects, on 3 March 2026, the Board of Directors has decided to withdraw its previously communicated long-term financial targets of over EUR 100 million revenue and an EBIT margin of over 30%* in 2027.

Canatu monitors its long-term financial targets on a continuous basis and reviews them more comprehensively, at least annually as part of its strategy review process. Canatu will communicate the results of its strategy update before the Capital Markets Day on 26 March 2026.

Key operative targets for 2026

Semiconductor

  • Maintain and strengthen competitive position in CNT reactor technology and inspection membranes
  • Complete the customer approval (Site Acceptance Test, SAT) for the 2nd CNT100 SEMI reactor
  • Sell at least one new CNT100 SEMI reactor during 2026
  • Receive recurring revenue from consumables and royalties on CNT pellicles sold
  • Enable multiple parallel reactor builds

Automotive

  • Start mass production of ADAS camera heaters with a lead customer
  • Complete ongoing joint development programs on CNT conductivity and large‑scale chamber
  • Advance the development of ADAS camera heater concept with an enhanced material configuration in windshield glass
  • Continue developing full windshield heaters and next‑generation solar cells
  • Sell one high-performance CNT100 HPR reactor

Medical Diagnostics

  • Develop one integrated proof-of-concept system and a functional alpha prototype for hormone monitoring
  • Publish scientific papers to build strong proof points

New business development

  • Evaluate 10 new applications and identify the most promising business cases, primarily from the microsystems and electrochemical sensing domains​
  • Sign 1 new development agreement with a credible industrial player